The University of Chicago Header Logo

Connection

Piyush Agarwal to Aged

Back to Details
This is a "connection" page, showing publications Piyush Agarwal has written about Aged.
Piyush Agarwal
Connection Strength
0.617
Aged
  1. Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors. Urol Oncol. 2025 Jan; 43(1):62.e7-62.e13.
    View in: PubMed
    Score: 0.070
  2. The impact of metabolic syndrome on short term radical cystectomy complications. Urol Oncol. 2024 Dec; 42(12):450.e23-450.e28.
    View in: PubMed
    Score: 0.069
  3. Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience. Diagn Interv Radiol. 2018 Sep; 24(5):316-320.
    View in: PubMed
    Score: 0.046
  4. Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7". Urology. 2018 Aug; 118:e3-e4.
    View in: PubMed
    Score: 0.045
  5. Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database. Int Urol Nephrol. 2018 Feb; 50(2):257-262.
    View in: PubMed
    Score: 0.044
  6. Effect of metabolic syndrome on pathologic features of prostate cancer. Urol Oncol. 2013 Oct; 31(7):1054-9.
    View in: PubMed
    Score: 0.030
  7. Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol. 2011 May; 59(5):684-98.
    View in: PubMed
    Score: 0.027
  8. Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J Urol. 2010 Jan; 183(1):118-24.
    View in: PubMed
    Score: 0.025
  9. Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer. Urol Oncol. 2011 Jul-Aug; 29(4):372-7.
    View in: PubMed
    Score: 0.024
  10. Vattikuti Institute prostatectomy: technical modifications in 2009. Eur Urol. 2009 Jul; 56(1):89-96.
    View in: PubMed
    Score: 0.024
  11. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol. 2005 Feb; 173(2):533-6.
    View in: PubMed
    Score: 0.018
  12. Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. J Clin Oncol. 2024 Sep 01; 42(25):3033-3046.
    View in: PubMed
    Score: 0.017
  13. Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2024 Jun; 188:80-86.
    View in: PubMed
    Score: 0.017
  14. Bladder-Preserving Trimodality Therapy With Capecitabine. Clin Genitourin Cancer. 2024 04; 22(2):476-482.e1.
    View in: PubMed
    Score: 0.017
  15. Incidence of Preoperative Antibiotic Use and Its Association with Postoperative Infectious Complications after Radical Cystectomy. Urology. 2022 06; 164:169-177.
    View in: PubMed
    Score: 0.015
  16. Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. J Clin Oncol. 2020 11 01; 38(31):3672-3684.
    View in: PubMed
    Score: 0.013
  17. Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Lancet Oncol. 2020 08; 21(8):1099-1109.
    View in: PubMed
    Score: 0.013
  18. Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study. AJR Am J Roentgenol. 2020 01; 214(1):105-113.
    View in: PubMed
    Score: 0.012
  19. Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer. J Immunol. 2019 06 15; 202(12):3458-3467.
    View in: PubMed
    Score: 0.012
  20. Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. Clin Epigenetics. 2018; 10:19.
    View in: PubMed
    Score: 0.011
  21. New facial papules in a 66-year-old woman with bladder cancer. J Am Acad Dermatol. 2014 Dec; 71(6):1250-5.
    View in: PubMed
    Score: 0.009
  22. Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States. Urol Oncol. 2014 Jul; 32(5):637-44.
    View in: PubMed
    Score: 0.009
  23. Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review. BJU Int. 2014 May; 113(5b):E28-33.
    View in: PubMed
    Score: 0.008
  24. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2014 Feb; 65(2):340-7.
    View in: PubMed
    Score: 0.008
  25. The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Urol Oncol. 2014 Jan; 32(1):29.e13-20.
    View in: PubMed
    Score: 0.008
  26. Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). BJU Int. 2013 Jun; 111(7):1075-80.
    View in: PubMed
    Score: 0.008
  27. Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2013 Jul; 64(1):52-7.
    View in: PubMed
    Score: 0.008
  28. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology. 2009 Jan; 73(1):147-52.
    View in: PubMed
    Score: 0.006
  29. Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J Urol. 2004 Apr; 171(4):1525-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.